Toll-like receptor 9 enhancement of antiviral immunity in chronic HIV-1 infection: a phase 1b/2a trial (TEACH)
Phase of Trial: Phase I/II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Lefitolimod (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms TEACH
- 09 Aug 2017 Detailed results of the extension phase will be presented at an international scientific conference, according to a Mologen media release.
- 09 Aug 2017 Results from the extension phase of this trial published in a Mologen media release.
- 28 Jun 2017 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History